Destination XL Group, Inc. (NASDAQ: DXLG) is evaluating an unsolicited cash tender offer of $0.82 per share from Zodiac Partners II, a move that complicates its existing merger agreement with FBB Holdings I, Inc., also known as FullBeauty.
"The DXL Board of Directors is carefully evaluating the Offer with its independent financial and legal advisors in furtherance of its fiduciary duties," the company said in a statement. DXL advised its shareholders to take no action pending the board's review.
The unsolicited offer from Zodiac was made on May 12, with DXL publicly acknowledging the review on May 22. Zodiac's $0.82 per share bid is an all-cash proposal, which the firm argues is a "superior" option for shareholders. This is set against DXL's prior agreement to merge with FullBeauty, the terms of which have not been fully disclosed.
For shareholders, the competing offers create a period of uncertainty but also potential for a higher final sale price. The board must now weigh the immediate cash value of Zodiac's offer against the long-term strategic value of the FullBeauty merger, with Zodiac's offer set to expire on June 22, 2026.
Zodiac Partners has been vocal about its intentions, stating its offer provides "an opportunity to realize immediate value at a large premium." The firm has criticized the proposed merger with FullBeauty, suggesting it would "add an unsustainable debt burden in a very uncertain macro environment." Zodiac has also indicated that DXL has not provided access to the necessary information for due diligence, a common tactic in hostile takeover situations.
Destination XL, a leading retailer of Big + Tall men's apparel, confirmed it will provide a formal recommendation to its shareholders within ten business days of the offer's announcement. The company has retained Guggenheim Securities as its financial advisor and Greenberg Traurig as its legal advisor to assist in the evaluation. The board's decision will be filed with the U.S. Securities and Exchange Commission.
The unsolicited bid from Zodiac puts DXL's board in a position to negotiate between two potential futures. The outcome will determine the company's ownership structure and strategic direction, impacting investors, employees, and customers.
The board's recommendation will be a critical catalyst for the stock. Investors will be watching for the Schedule 14D-9 filing, which will detail the board's reasoning and officially recommend to either accept or reject Zodiac's offer.
This article is for informational purposes only and does not constitute investment advice.
